Neuroimaging in CMV congenital infected neonates: how and when.
Neonatal congenital infections are an important cause of mortality, morbidity and long-term neurodevelopmental and sensorineural sequelae. Many pathogens can cause in utero infection, and among them, cytomegalovirus (CMV) plays a prominent role. In developed countries, CMV poses major health problems as it is the most common pathogen leading to congenital infection, and the leading cause of nonhereditary deafness in children. Evaluation of central nervous system (CNS) involvement in congenital CMV infected newborns is mandatory to better assess the severity of the disease, to guide adequate treatment, to define prognosis, and to tailor follow-up observations and parents' counselling. Cerebral ultrasonography (cUS), Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) are the currently available techniques to evaluate infants with suspected or proven congenital CMV infection. In congenital CMV infection, their role in early detection and confirmation of cerebral involvement within the first month of life is crucial to initiate specific treatment with antivirals. Neonatologists, paediatricians and radiologists should be aware of the role, the limitations and the inherent risks related to the use of these specific neuroimaging diagnostic tools in these infants. In this article we will discuss from a neonatological perspective the advantages, disadvantages, risks and limitations of each imaging technique.
Paediatric Department S Maria della Scaletta General Hospital, Imola, Bologna, Italy. m.lanari@ausl.imola.bo.it
M
M
Lanari
M G
MG
Capretti
T
T
Lazzarotto
L
L
Gabrielli
S
S
Rizzollo
M
M
Mostert
P
P
Manzoni
D020805:Central Nervous System Viral Diseases / Q000151:congenital* / Q000175:diagnosis*; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000175:diagnosis* / Q000000981:diagnostic imaging; D006801:Humans; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging / Q000009:adverse effects / Q000379:methods; D064847:Multimodal Imaging / Q000009:adverse effects / Q000379:methods; D059906:Neuroimaging / Q000009:adverse effects / Q000379:methods*; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed / Q000009:adverse effects / Q000379:methods; D014463:Ultrasonography